These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29569503)

  • 1. Evolving models of collaborative drug discovery: managing intellectual capital assets.
    Allarakhia M
    Expert Opin Drug Discov; 2018 Jun; 13(6):473-476. PubMed ID: 29569503
    [No Abstract]   [Full Text] [Related]  

  • 2. Opening the lead generation toolbox.
    Simpson PB; Reichman M
    Nat Rev Drug Discov; 2014 Jan; 13(1):3-4. PubMed ID: 24378783
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement.
    Allarakhia M
    Expert Opin Drug Discov; 2015 Jun; 10(6):571-8. PubMed ID: 25872566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound Passport Service: supporting corporate collection owners in open innovation.
    Andrews DM; Degorce SL; Drake DJ; Gustafsson M; Higgins KM; Winter JJ
    Drug Discov Today; 2015 Oct; 20(10):1250-5. PubMed ID: 26136162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
    Bryans JS; Kettleborough CA; Solari R
    Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
    [No Abstract]   [Full Text] [Related]  

  • 8. Crowdsourcing in pharma: a strategic framework.
    Bentzien J; Bharadwaj R; Thompson DC
    Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 11. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. China spurs pharma innovation.
    Hughes B
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract]   [Full Text] [Related]  

  • 13. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 14. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 15. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic R&D transactions in personalized drug development.
    Makino T; Lim Y; Kodama K
    Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
    Kaski JC
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
    DeCorte BL
    J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.